Page last updated: 2024-10-24

candesartan and Asthma

candesartan has been researched along with Asthma in 3 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research Excerpts

ExcerptRelevanceReference
"Angiotensin II is a putative mediator in bronchial asthma."9.10Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. ( Fujimura, M; Hashimoto, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Watanabe, K, 2002)
"Candesartan, an AT(1) receptor antagonist, has been reported to have no association with persistent cough in subjects with hypertension, but there has been no study on the safety of its administration to hypertensive patients with symptomatic asthma."9.09Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. ( Abe, S; Hashimoto, M; Oashi, K; Saikai, T; Suzuki, K; Tanaka, H; Tanaka, S; Teramoto, S, 2001)
"The effects of candesartan and irbesartan, antagonists of the type I angiotensin II receptor, were investigated on allergic asthma."7.91Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma. ( Im, DS; Kim, MJ, 2019)
"Angiotensin II is a putative mediator in bronchial asthma."5.10Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. ( Fujimura, M; Hashimoto, T; Ishiura, Y; Kamio, Y; Kita, T; Myou, S; Nakao, S; Watanabe, K, 2002)
"Candesartan, an AT(1) receptor antagonist, has been reported to have no association with persistent cough in subjects with hypertension, but there has been no study on the safety of its administration to hypertensive patients with symptomatic asthma."5.09Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. ( Abe, S; Hashimoto, M; Oashi, K; Saikai, T; Suzuki, K; Tanaka, H; Tanaka, S; Teramoto, S, 2001)
"The effects of candesartan and irbesartan, antagonists of the type I angiotensin II receptor, were investigated on allergic asthma."3.91Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma. ( Im, DS; Kim, MJ, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, MJ1
Im, DS1
Myou, S1
Fujimura, M1
Kamio, Y1
Kita, T1
Watanabe, K1
Ishiura, Y1
Hashimoto, T1
Nakao, S1
Tanaka, H1
Teramoto, S1
Oashi, K1
Saikai, T1
Tanaka, S1
Suzuki, K1
Hashimoto, M1
Abe, S1

Trials

2 trials available for candesartan and Asthma

ArticleYear
Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma.
    British journal of clinical pharmacology, 2002, Volume: 54, Issue:6

    Topics: Administration, Inhalation; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Asthma; B

2002
Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma.
    Circulation, 2001, Jul-17, Volume: 104, Issue:3

    Topics: Adult; Aged; Antihypertensive Agents; Asthma; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Br

2001

Other Studies

1 other study available for candesartan and Asthma

ArticleYear
Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma.
    European journal of pharmacology, 2019, Jun-05, Volume: 852

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Allergic Agents; Asthma; Benzimidazoles; Biph

2019